drugset / Trial / NCT03549598

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

NCT03549598

Phase 4 Completed 15 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.

Timeline

Start
2018-07-20
Primary completion
2019-10-02
Completion
2019-10-02

Drugs

EvaluationDrugModalityDoseRoute
Subject 13NH3 Diagnostic / imaging agent Intravenous
Subject 18F-FDG Diagnostic / imaging agent Intravenous
Subject 68Ga-DOTATATE Diagnostic / imaging agent 199.8 mbq Intravenous

Indications